News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,952 Results
Type
Article (53708)
Company Profile (666)
Press Release (691578)
Multimedia
Podcasts (100)
Webinars (14)
Section
Business (212011)
Career Advice (3386)
Deals (37647)
Drug Delivery (121)
Drug Development (85281)
Employer Resources (185)
FDA (17188)
Job Trends (16265)
News (362436)
Policy (34945)
Tag
Academia (2807)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (52197)
ALS (98)
Alzheimer's disease (1481)
Antibody-drug conjugate (ADC) (153)
Approvals (17153)
Artificial intelligence (285)
Autoimmune disease (28)
Automation (15)
Bankruptcy (388)
Best Places to Work (12287)
BIOSECURE Act (22)
Biosimilars (113)
Biotechnology (460)
Bladder cancer (83)
Brain cancer (31)
Breast cancer (299)
Cancer (2404)
Cardiovascular disease (196)
Career advice (2860)
Career pathing (34)
CAR-T (172)
Cell therapy (481)
Cervical cancer (20)
Clinical research (69079)
Collaboration (905)
Compensation (535)
Complete response letters (30)
COVID-19 (2795)
CRISPR (48)
C-suite (264)
Cystic fibrosis (106)
Data (2247)
Decentralized trials (2)
Denatured (28)
Depression (52)
Diabetes (291)
Diagnostics (6783)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (45)
Drug discovery (133)
Drug pricing (119)
Drug shortages (32)
Duchenne muscular dystrophy (101)
Earnings (86240)
Editorial (44)
Employer branding (24)
Employer resources (158)
Events (122659)
Executive appointments (766)
FDA (18464)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (800)
Gene editing (119)
Generative AI (25)
Gene therapy (354)
GLP-1 (831)
Government (4773)
Grass and pollen (6)
Guidances (57)
Healthcare (19943)
Huntington's disease (23)
IgA nephropathy (31)
Immunology and inflammation (144)
Indications (30)
Infectious disease (2948)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (100)
Interviews (663)
IPO (17461)
IRA (49)
Job creations (4472)
Job search strategy (2339)
Kidney cancer (10)
Labor market (39)
Layoffs (546)
Leadership (24)
Legal (8467)
Liver cancer (81)
Lung cancer (342)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (342)
MASH (74)
Medical device (14358)
Medtech (14363)
Mergers & acquisitions (20740)
Metabolic disorders (767)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2072)
NextGen: Class of 2025 (7264)
Non-profit (4593)
Now hiring (40)
Obesity (414)
Opinion (272)
Ovarian cancer (77)
Pain (96)
Pancreatic cancer (85)
Parkinson's disease (159)
Partnered (22)
Patents (245)
Patient recruitment (113)
Peanut (51)
People (61069)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (21588)
Phase II (30408)
Phase III (22849)
Pipeline (1231)
Policy (166)
Postmarket research (2572)
Preclinical (9191)
Press Release (68)
Prostate cancer (112)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (427)
Real estate (6551)
Recruiting (73)
Regulatory (23963)
Reports (41)
Research institute (2505)
Resumes & cover letters (537)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (79)
Series A (142)
Series B (91)
Service/supplier (26)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (157)
Sponsored (34)
Startups (4057)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (44)
The Weekly (71)
Vaccines (789)
Venture capitalists (44)
Weight loss (291)
Women's health (34)
Worklife (20)
Date
Today (171)
Last 7 days (896)
Last 30 days (2767)
Last 365 days (35036)
2025 (11275)
2024 (37583)
2023 (42222)
2022 (53486)
2021 (58085)
2020 (56547)
2019 (49424)
2018 (37605)
2017 (35530)
2016 (35461)
2015 (41215)
2014 (34317)
2013 (29007)
2012 (30655)
2011 (31031)
2010 (28796)
Location
Africa (987)
Alabama (59)
Alaska (7)
Arizona (211)
Arkansas (14)
Asia (45586)
Australia (7603)
California (6374)
Canada (2048)
China (559)
Colorado (280)
Connecticut (296)
Delaware (155)
Europe (99608)
Florida (931)
Georgia (217)
Hawaii (1)
Idaho (60)
Illinois (597)
India (29)
Indiana (328)
Iowa (12)
Japan (166)
Kansas (106)
Kentucky (25)
Louisiana (13)
Maine (66)
Maryland (903)
Massachusetts (4906)
Michigan (241)
Minnesota (415)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (63)
New Hampshire (68)
New Jersey (1803)
New Mexico (31)
New York (1810)
North Carolina (1110)
North Dakota (8)
Northern California (2730)
Ohio (213)
Oklahoma (15)
Oregon (46)
Pennsylvania (1407)
Puerto Rico (13)
Rhode Island (36)
South America (1366)
South Carolina (21)
South Dakota (1)
Southern California (2357)
Tennessee (100)
Texas (949)
United States (24322)
Utah (190)
Virginia (164)
Washington D.C. (67)
Washington State (598)
West Virginia (3)
Wisconsin (64)
745,952 Results for "the native antigen company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies
April 21, 2025
·
1 min read
The Native Antigen Company Introduces New Range of Influenza Antigens
The Native Antigen Company (part of LGC Clinical Diagnostics) today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.
November 18, 2022
·
2 min read
Press Releases
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
April 28, 2025
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Press Releases
AUA 2025: New Data from Post-Hoc Analyses Shared on Ultra-Low Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Hormone-Sensitive Prostate Cancer Receiving NUBEQA® (darolutamide) plus Androgen Deprivation Therapy (ADT)
April 30, 2025
·
13 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
Press Releases
ATED Therapeutics, Ltd.: New Rapid, Simple Blood Test for Parkinson’s Disease Developed
April 14, 2025
·
2 min read
Cancer
Merck and Epitopea Join Forces to Identify Unknown Tumor Antigens
The agreement, in which Merck will pay the biotech an undisclosed initial sum to license drugs targeting a solid tumor, could net Epitopea up to $300 million down the line.
February 19, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare’s Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test
January 21, 2025
·
3 min read
1 of 74,596
Next
